Navigation Links
GeoVax Awarded $3.6 Million Grant by U.S. Government for its HIV/AIDS Vaccine Program
Date:8/16/2011

ATLANTA, Aug. 16, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based, biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced receipt of a $3.6 million annual notice of award for the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant supporting GeoVax's HIV/AIDS vaccine program.

This grant was originally awarded in 2007 to GeoVax by the National Institutes of Health-National Institute of Allergy & Infectious Disease (NIH-NIAID), an agency of the U.S. Government.  Only meritorious HIV/AIDS prevention vaccine candidates are considered to receive an IPCAVD award.

This most recent annual award represents the fifth year's award, bringing the aggregate award to date to $19.6 million.  GeoVax will utilize this funding to further production of its GM-CSF adjuvanted vaccine for planned human clinical trials.

"This award will allow us to maintain momentum on the successful development of our GM-CSF adjuvanted vaccine," said Harriet Robinson, Ph.D., Chief Scientific Officer of GeoVax and Program Director for the Award. "Depending on FDA submission schedules, we anticipate beginning a Phase 1 clinical trial within the next six months.  The exciting thing about using the GM-CSF adjuvant is that it significantly increases prevention of infection.  Without the adjuvant, our vaccine has been demonstrated to successfully control infection, but prevention of infection is the ultimate goal.  There is widespread enthusiasm and desire for a vaccine that provides the promise for prevention of infection."

"We just had our annual External Advisory Board Meeting for our GM-CSF adjuvant project," said Robert McNally, Ph.D., President & CEO of GeoVax.  "It was very productive with the outside experts being highly enthusiastic about the GM-CSF adjuvanted vaccine and very complimentary of the progress
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine
2. Article by GeoVax Labs CSO Featured in The Scientist
3. GeoVax Labs Announces Availability of 2010 Annual Report and Presidents Letter to Stockholders
4. GeoVax Labs, Inc. Announces First Quarter Financial Results
5. GeoVax Labs Reports Fourth Quarter and Year-End 2010 Financial Results
6. GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony
7. GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting
8. GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
9. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
10. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
11. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 23, 2014 Earlier this year in ... Sherley, director of the Adult Stem Cell Technology Center, ... overlooked and under appreciated unique property of adult tissue ... Stem Cells: Misunderstood in the Past, Important for the ... participants. He gave the address at the 4th ...
(Date:12/24/2014)... 23, 2014 The report ... as its definition, classification, application and industry ... manufacturing process, and product cost structure. Production ... The analysis also covers upstream raw materials, ... development trend and proposals. In the end, ...
(Date:12/24/2014)... 2014 China Biologic Products, Inc. (NASDAQ: ... fully integrated plasma-based biopharmaceutical company in ... subsidiary, Shandong Taibang Biological Products Co. Ltd., has ... China Food and Drug Administration (the "CFDA") for ... disclosed in the Company,s public filings, the CFDA ...
(Date:12/24/2014)... Fla. , Dec. 23, 2014  Rock Creek ... that it has filed a Clinical Trial Application (CTA) ... Healthcare products Regulatory Agency (MHRA) seeking regulatory approval to ... lead molecule, Anatabine Citrate. Contingent on the ... conduct a Phase I trial to assess the safety, ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) will be presenting ... on Wednesday, June 11, 2008 at 1:20,p.m. PT. Daniel ... will be providing a corporate overview., The live ... be made,available following the event. The Web cast and ...
... Sidec has of today introduced,a new version of ... the analysis of therapeutic antibodies and,drug targets in ... Protein Tomography(TM) uses regularization theory to create ... microscope images. The enhanced Protein,Tomography(TM) method is developed ...
... PRXL ) announced today it will be presenting ... The Ritz Carlton,- Laguna Niguel in Dana Point, California. ... be making a formal presentation,on PAREXEL at 4:40 p.m. ... webcast of this presentation will be available under the,"Upcoming ...
Cached Biology Technology:PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference 2
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... a progressive degenerative disease affecting a person,s ability to ... as a tremor in a finger will eventually lead ... inability to walk without assistance. Since the 1950s research ... of the chemical dopamine in their brains, which is ...
... April 23, 2013  According to ... Market (2013 - 2018): by Technology (2D, 3D, Ultrasonic, IR, Capacitive); Product ... , China , Japan ... & Oceania)", is expected to reach $4.18 billion by 2018 ...
... 22, 2013) The current special issue of ... Academy of Inventors ( https://www.cognizantcommunication.com/component/content/article/636 ), devoted to studies ... a wide range of topics, from new technologies to ... human microbiome. "This special issue of ...
Cached Biology News:New research examines connection between inflammatory stimulus and Parkinson's disease 2New research examines connection between inflammatory stimulus and Parkinson's disease 3Asia-Pacific Gesture Recognition & Touchless Sensing Market Worth $4.18 Billion by 2018 2Asia-Pacific Gesture Recognition & Touchless Sensing Market Worth $4.18 Billion by 2018 3Asia-Pacific Gesture Recognition & Touchless Sensing Market Worth $4.18 Billion by 2018 4Technology transforms health care 2Technology transforms health care 3
... Microarrays designed for RNA aptamer screening and ... and powerful Paraflo microfluidic on-chip synthesis platform. ... be synthesized on-chip and LC Sciences can ... microarrays are available as part of our ...
... a synthetic peptide whose sequence is from the C-terminal end of the ... extends from amino acids 429 to 448 of RAR*. The sequence ... - V - S - P - S - S - V ... - Q - S - P - L - L - Q ...
... The ELx50 is a fast and versatile ... with our patented Dual-ActionTM 16-channel manifold. This ... the dispense and aspiration manifolds for overfill ... and 384-well formats. The problem of fitting ...
... glutathione-S-transferase (GST) is commonly used as a ... coli (1). The GSTTag sequence has been ... some cases the solubility of its fusion ... folded form, GSTTag fusion proteins can be ...
Biology Products: